Healthcare
Live Price
Offline$0.35
-41.86% today
1Y Change
-22.26%
Window
Jun 23, 2025 → May 29, 2026
Coverage: 236 bars · Jun 23, 2025 → May 29, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Tenon Medical, Inc. (TNON) is a Healthcare stock with a market cap of $10.00M and listed on NASDAQ. The stock last traded around $0.35 and down 22.3% across the available one-year price window (Jun 23, 2025 → May 29, 2026). Baseline metrics include revenue growth of +20.4%, EPS growth of +84.9%, a dividend yield of 0.0%. What stands out right now is revenue +20.4%, EPS +84.9%, free cash flow -9.5% with operating margin -323.6% and ROIC -166.8%. Valuation is more restrained than many high-expectation growth names at price/sales 1.5. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines TNON price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
TNON
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
TNON Max Drawdown
-60.13%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for TNON and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$160.0K
-76.8% YoY
FY Net Income
-$7.0M
+62.7% YoY
Free Cash Flow
-$4.4M
+65.9% YoY
Revenue Growth
+20.4%
EPS Growth
+84.9%
Gross Margin
59.1%
Net Margin
-316.0%
Income statement
USD
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 4M | 3M | 3M | 691K | 160K |
| Gross Profit | 2M | 2M | 1M | -641K | 105K |
| Operating Income | -13M | -14M | -16M | -19M | -6M |
| EBITDA | -13M | -13M | -15M | -18M | -6M |
| Net Income | -13M | -14M | -16M | -19M | -7M |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
USD
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Cash & Equivalents | 4M | 7M | 2M | 2M | 3M |
| Total Assets | 11M | 10M | 6M | 11M | 9M |
| Total Liabilities | 6M | 4M | 6M | 5M | 30M |
| Shareholder Equity | 5M | 6M | 778K | 6M | -21M |
| Total Debt | 141K | 428K | 2M | 911K | 15M |
| Net Debt | -4M | -6M | -571K | -1M | 12M |
Cash flow positioning
Latest Full Year
Operating Cash Flow
4M
+64.3% YoY
Capital Expenditures
102K
+88.0% YoY
Free Cash Flow
4M
+65.9% YoY
Key ratios
Gross Margin
59.1%
Operating Margin
-323.6%
Net Margin
-316.0%
ROE
-193.2%
Debt / Equity
0.03x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.